Viewing Study NCT02390492


Ignite Creation Date: 2025-12-24 @ 3:20 PM
Ignite Modification Date: 2026-01-05 @ 5:21 PM
Study NCT ID: NCT02390492
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2015-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Bioavailability and Pharmacokinetic Study of [14C]-Ipatasertib Single Oral and Intravenous Doses in Healthy Male Subjects
Sponsor: Genentech, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module